Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases

Advances in lncRNAs from stem cell-derived exosome for the treatment of cardiovascular diseases

Cardiovascular diseases (CVDs) are the leading cause of mortality globally. Benefiting from the advantages of early diagnosis and precision medicine, stem cell-based therapies have emerged as promising treatment options for CVDs. However, autologous or allogeneic stem cell transplantation imposes a...

Full description

Bibliographic Details
Main Authors: Jiahui Ma, Pengyu Lei, Haojie Chen, Lei Wang, Yimeng Fang, Xiaoqing Yan, Qinsi Yang, Bo Peng, Libo Jin, Da Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
lncRNA
exosome
stem cells
cardiovascular diseases
acellular therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.986683/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.986683/full

Similar Items